Mitral Valve Screening Survey
ConditionMitral Valve Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedstar Health Research Institute
About this trial
This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).
Eligibility criteria
Qualifiers
Subject failed screening for TMVI
Disqualifiers
Under 18 years of age
Subject unable or unwilling to give informed consent
Subject proceeded with TMVI.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,000 Participants
are grouped into 1 trial groupLocations
16Canada
St. Paul's Hospital VancouverBritish Columbia, Canada
Unity Health Toronto; St. Michael's Hospital TorontoOntario, Canada
United States
Arizona
Phoenix Cardiovascular Research Group85016, Phoenix United States
California
Keck Hospital of USC90033, Los Angeles United States
Sponsors and collaborators
Medstar Health Research Institute
Lead sponsor
Source ClinicalTrials.gov